title: Microtubules are required for cytokeratin aggresome (Mallory body) formation in hepatocytes: an in vitro study.
abstract: Mallory bodies are cytokeratin-ubiquitin aggresomes that form in hepatocytes in many different chronic liver diseases. One of the key components in aggresome formation, not yet investigated in Mallory body formation, is the role of microtubules. An in vitro tissue culture assay is required to test for microtubule involvement in Mallory body formation so that Mallory body formation can be observed in the presence or absence of microtubule-disrupting agents. In this report, a new model of in vitro Mallory body formation was developed, which uses cultured hepatocytes isolated from drug-primed mice. When hepatocytes were incubated in the presence of antimicrotubule agents, they failed to form Mallory bodies. It is concluded that intact microtubules are required for Mallory body formation.
authors.affiliation: Department of Pathology, Harbor-UCLA Medical Center, 1000 W. Carson Street, Torrance, CA 90509, USA.
authors.forename: N E
authors.initials: NE
authors.lastname: Riley
authors.forename: F
authors.initials: F
authors.lastname: Bardag-Gorce
authors.forename: R O
authors.initials: RO
authors.lastname: Montgomery
authors.forename: J
authors.initials: J
authors.lastname: Li
authors.forename: W
authors.initials: W
authors.lastname: Lungo
authors.forename: Y H
authors.initials: YH
authors.lastname: Lue
authors.forename: S W
authors.initials: SW
authors.lastname: French
mesh_terms: D000818:Animals; D000906:Antibodies / Q000378:metabolism; D002478:Cells, Cultured; D003078:Colchicine / Q000494:pharmacology; D004095:Dihydropyridines / Q000494:pharmacology; D022781:Hepatocytes / Q000187:drug effects / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D002479:Inclusion Bodies / Q000737:chemistry / Q000378:metabolism* / Q000473:pathology*; D007633:Keratins / Q000378:metabolism*; D008099:Liver / Q000187:drug effects / Q000378:metabolism / Q000473:pathology* / Q000648:ultrastructure; D008162:Lumicolchicines / Q000494:pharmacology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D008870:Microtubules / Q000187:drug effects / Q000502:physiology*; D015739:Nocodazole / Q000494:pharmacology; D025801:Ubiquitin / Q000378:metabolism
chemical_list: D000906:Antibodies; D004095:Dihydropyridines; D008162:Lumicolchicines; D025801:Ubiquitin; C042109:lumicolchicine; D007633:Keratins; D015739:Nocodazole; D003078:Colchicine